HCA Healthcare Inc. presents a distinctive profile among hospital operators, with systematic screening revealing an extraordinary ROE of 695.73% driven by a highly leveraged capital structure reflected in its debt-to-equity ratio of 54.2. Trading at $402.59 with a market capitalization of $87.2 billion, the company operates at the lower end of its 52-week range of $342.71–$556.52, generating a TTM P/E ratio of 12.86 that appears compressed relative to recent earnings momentum showing 29.19% year-over-year EPS growth.

Operational strengths include:

• Robust profitability metrics with an 85.0% gross margin and 8.89% net margin, demonstrating effective cost management across the hospital network
• Strong return on assets of 11.26%, indicating efficient deployment of the company's $87.2 billion asset base
• Steady revenue expansion of 6.71% year-over-year alongside accelerating bottom-line growth, with EPS reaching $29.08

Risk considerations include:

• The current ratio of 0.97 flags potential liquidity constraints, falling below the 1.0 threshold that typically indicates adequate short-term asset coverage
• Extreme leverage evidenced by the 54.2 debt-to-equity ratio creates sensitivity to interest rate fluctuations and refinancing risk
• Book value per share of just $1.69 paired with a P/B ratio of 97.29 reflects the highly levered equity base

Compared to peers THC, EHC, and ENSG, HCA's scale and valuation multiple of 1.14 times sales positions the company as a large-cap leader navigating the balance between growth investment and capital structure optimization in the hospital sector.